Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.
- DOI
- 10.1016/s2665-9913(25)00071-2
- Published
- 2025 Oct
- Container
- The Lancet. Rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2665-9913-25-00071-2,
title = {Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.},
author = {Morel J and Dernis E and Roux C and Richez C and Brocq O and Fautrel B and Salliot C and Vittecoq O and Mariette X and Lioté F and Lassoued S and Gaujoux-Viala C and Constantin A and Soubrier M and Devauchelle-Pensec V and Goeb V and Gottenberg JE and Marotte H and Moulard AR and Daien C and Mouterde G and Lukas C and Pissarra J and Huguet H and Launay O and Galtier F and Picot MC and I-REIVAC and CRI-IMIDIATE French Clinical Research Networks},
year = {2025},
journal = {The Lancet. Rheumatology},
doi = {10.1016/s2665-9913(25)00071-2},
url = {https://doi.org/10.1016/s2665-9913(25)00071-2}
}RIS
TY - JOUR TI - Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial. AU - Morel J AU - Dernis E AU - Roux C AU - Richez C AU - Brocq O AU - Fautrel B AU - Salliot C AU - Vittecoq O AU - Mariette X AU - Lioté F AU - Lassoued S AU - Gaujoux-Viala C AU - Constantin A AU - Soubrier M AU - Devauchelle-Pensec V AU - Goeb V AU - Gottenberg JE AU - Marotte H AU - Moulard AR AU - Daien C AU - Mouterde G AU - Lukas C AU - Pissarra J AU - Huguet H AU - Launay O AU - Galtier F AU - Picot MC AU - I-REIVAC AU - CRI-IMIDIATE French Clinical Research Networks PY - 2025 JO - The Lancet. Rheumatology DO - 10.1016/s2665-9913(25)00071-2 UR - https://doi.org/10.1016/s2665-9913(25)00071-2 ER -
APA
J, M., E, D., C, R., C, R., O, B., B, F., C, S., O, V., X, M., F, L., S, L., C, G., A, C., M, S., V, D., V, G., JE, G., H, M., AR, M., C, D., G, M., C, L., J, P., H, H., O, L., F, G., MC, P., I-REIVAC, & Networks, C. F. C. R. (2025). Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(25)00071-2
Source records
- pubmed · retrieved 2026-09-27T16:30:20.042Z